Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.

There is a continuing search for better ways to use existing drugs against human immunodeficiency virus (HIV). One idea is to use short therapy interruptions to "autovaccinate" HIV-infected patients. A group of 13 chronically HIV-infected patients enrolled in a trial of such so-called stru...

Full description

Bibliographic Details
Main Authors: Oxenius, A, Mclean, A, Fischer, M, Price, D, Dawson, S, Hafner, R, Schneider, C, Joller, H, Hirschel, B, Phillips, R, Weber, R, Günthard, H
Format: Journal article
Language:English
Published: 2002